#drug-supply
(6 articles)Trump's Trade Shift Disrupting Pharma Supply Chains
The Trump administration's evolving trade policies are creating structural changes in how pharmaceutical companies source materials and manufacture medications. The shift away from traditional relianc
Tariffs and Geopolitical Shifts Reshape Pharma Supply Networks
Global pharmaceutical supply chains face structural disruption from escalating tariffs and geopolitical tensions, forcing companies to reconsider decades-old sourcing and distribution strategies. The
Geopolitical Risk Threatens Pharmaceutical Supply Chains in 2026
DSV has identified significant geopolitical risks that are poised to reshape pharmaceutical supply chains throughout 2026. These include trade policy uncertainties, regional tensions, and shifting reg
Weather Disasters Threaten US Pharmaceutical Supply Chain
Recent research highlights an emerging structural vulnerability in the US pharmaceutical supply chain: weather-related disasters pose systematic risks to drug distribution networks. Unlike localized s
Weather Disasters Threaten U.S. Drug Supply Chain Resilience
Research from the American Chemical Society highlights an emerging structural vulnerability in U.S. pharmaceutical supply chains: increasing weather disasters and climate volatility are creating syste
Pharma Supply Chain Faces Major Tariff Overhaul in 2025
The pharmaceutical industry faces a structural reconfiguration of its supply chain in 2025 due to sweeping tariff policy changes. These tariffs represent a significant departure from decades of predic